Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert Gniadecki

Showing results (11-20 of 216) with videos related to

Pageof 22
Sort By:
Acta Dermato-Venereologica|September 7, 2006
Severe exacerbation of psoriatic arthritis during treatment with efalizumab. A case reportBo Bang, Robert Gniadecki
Neuro Endocrinology Letters|July 20, 2001
Induction of endothelial nitric oxide synthase in perivascular mast cells in rat neurohypophysis after ischemiaBarbara Gajkowska, Robert Gniadecki
Canadian Family Physician Medecin De Famille Canadien|June 14, 2019
Differentiating malignant melanoma from other lesions using dermoscopyRobert Gniadecki, Ahmed Mourad
Journal of the American Academy of Dermatology|February 23, 2025
Pneumocystis jirovecii pneumonia prophylaxis in patients with chronic inflammatory skin diseases: Systematic review and meta-analysisSamia Rahman, Robert Gniadecki
Ugeskrift for Laeger|March 31, 2006
[Dermatology--new therapeutic possibilities. The Danish Society of Dermatology]Robert Gniadecki, Merete Haedersdal
Archives of Dermatology|March 23, 2005
Monoclonal T-cell dyscrasia of undetermined significance associated with recalcitrant erythrodermaRobert Gniadecki, Ansgar Lukowsky
Acta Dermato-Venereologica|June 19, 2004
Infliximab (Remicade) for acute, severe pustular and erythrodermic psoriasisSteen Lisby, Robert Gniadecki
Ugeskrift for Laeger|June 21, 2008
[Biologics in skin diseases other than psoriasis]Robert Gniadecki, Lone Skov
Experimental Dermatology|June 19, 2008
TNF-alpha stimulates Akt by a distinct aPKC-dependent pathway in premalignant keratinocytesAnnesofie Faurschou, Robert Gniadecki
SAGE Open Medical Case Reports|March 25, 2024
Use of Baricitinib in a patient with treatment-resistant pyoderma gangrenosumKaylin Bechard, Robert Gniadecki
Pageof 22

Showing results (11-20 of 216) with videos related to

Sort By:
Pageof 22
Acta Dermato-Venereologica|September 7, 2006
Severe exacerbation of psoriatic arthritis during treatment with efalizumab. A case reportBo Bang, Robert Gniadecki
Neuro Endocrinology Letters|July 20, 2001
Induction of endothelial nitric oxide synthase in perivascular mast cells in rat neurohypophysis after ischemiaBarbara Gajkowska, Robert Gniadecki
Canadian Family Physician Medecin De Famille Canadien|June 14, 2019
Differentiating malignant melanoma from other lesions using dermoscopyRobert Gniadecki, Ahmed Mourad
Journal of the American Academy of Dermatology|February 23, 2025
Pneumocystis jirovecii pneumonia prophylaxis in patients with chronic inflammatory skin diseases: Systematic review and meta-analysisSamia Rahman, Robert Gniadecki
Ugeskrift for Laeger|March 31, 2006
[Dermatology--new therapeutic possibilities. The Danish Society of Dermatology]Robert Gniadecki, Merete Haedersdal
Archives of Dermatology|March 23, 2005
Monoclonal T-cell dyscrasia of undetermined significance associated with recalcitrant erythrodermaRobert Gniadecki, Ansgar Lukowsky
Acta Dermato-Venereologica|June 19, 2004
Infliximab (Remicade) for acute, severe pustular and erythrodermic psoriasisSteen Lisby, Robert Gniadecki
Ugeskrift for Laeger|June 21, 2008
[Biologics in skin diseases other than psoriasis]Robert Gniadecki, Lone Skov
Experimental Dermatology|June 19, 2008
TNF-alpha stimulates Akt by a distinct aPKC-dependent pathway in premalignant keratinocytesAnnesofie Faurschou, Robert Gniadecki
SAGE Open Medical Case Reports|March 25, 2024
Use of Baricitinib in a patient with treatment-resistant pyoderma gangrenosumKaylin Bechard, Robert Gniadecki
Pageof 22